Objective-Activation of the immune system via toll-like receptors (TLRs) is implicated in atherosclerosis, microvascular complications, and angiogenesis. However, the involvement of TLRs in inflammation-associated angiogenesis in ischemic neural tissue has not been investigated. The goal of this study is to determine the role of TLR4 signaling in oxygeninduced neovascularization in retina, a neural tissue. Methods and Results-In oxygen-induced retinopathy model, we found that retinal neovascularization was significantly attenuated in TLR4 −/− mice. The further study revealed that the absence of TLR4 led to downregulation of proinflammatory factors in association with the attenuated activation of glia in the ischemic retina, which was also associated with reduced expression of high-mobility group box-1, an endogenous ligand for TLR4. The application of high-mobility group box-1 to the ischemic retina promoted the production of proinflammatory factors in wild-type but not TLR4 −/− mice. Highmobility group box-1 treatment in vitro also significantly promoted the production of proinflammatory factors in retinal glial cells from wild-type mice, but much less from TLR4 −/− mice. Conclusion-Our results suggest that the release of high-mobility group box-1 in ischemic neural tissue initiates TLR4-dependent responses that contribute to neovascularization. These findings represented a previously unrecognized effect of TLR4 on angiogenesis in association with the activation of glia in ischemic neural tissue. 
I
ncreasing evidence has demonstrated that inflammation is an important pathogenetic factor in the development of vascular injury and angiogenesis. The inflammatory responses often present in angiogenesis can be called inflammationassociated neovascularization.
1,2 Activation of the immune system via toll-like receptors (TLRs) is implicated in several vascular-related diseases, including atherosclerosis, [3] [4] [5] diabetic nephropathy, 6 and tumor angiogenesis. 7 The mechanism of TLR mediation of inflammation-associated angiogenesis, however, has not been investigated in ischemic neural tissue.
TLRs, a family of evolutionarily preserved pattern recognition receptors, have emerged as a key component of the innate immune and adaptive immune system. 8, 9 Pathological angiogenesis is linked to inflammatory responses through the production of proinflammatory or proangiogenic mediators by the involved cells, which might express TLRs. 3, 4, 10 Among the 13 TLRs, TLR2 and TLR4 have been reported to play a critical role in inflammation-associated angiogenesis. 4, 11 It has been shown that, in the absence of pathogens, TLR4 signaling can be activated by molecules released by injured tissue. These molecules, called damage-associated molecular patterns, include high-mobility group box-1 (HMGB1), a nearly ubiquitous chromatin component that is passively released by necrotic cells, retained by cells undergoing programmed death (apoptosis), and actively secreted by cells in profound distress. [12] [13] [14] HMGB1 has been shown to enhance vessel density in skin wounds of diabetic mice and to increase the release of angiogenic factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). 15, 16 Beijnum reported the role of HMGB1 in tumor angiogenesis by showing that its overexpression is associated with an increased angiogenic potential of endothelial cells. 7 In a previous study, we also found that corneal injury can initiate HMGB1 release, which is involved in corneal angiogenesis by activating TLR4 signaling. 17 TLR4 has been reported to have broad expression in the central nervous system. [18] [19] [20] [21] In addition to being expressed on the classic immune cells, TLRs are also expressed on the endothelial, neuronal, and glial cells, exerting their inflammatory effects in various vascular and neural pathological conditions, including atherosclerosis, 22, 23 ischemia-reperfusion injury, 24 Alzheimer disease, 25 and the model of acute and chronic seizures in the central nervous system. 21 The retina is a neural tissue comprising large numbers of neurons, glia, and microvascular network. It is highly sensitive in response to oxygen deficiency. Because the HMGB1-TLR4 axis has been implicated in the inflammatory process of many disease models, [26] [27] [28] [29] and the proinflammatory role of TLR4 in several vasculature-related disorders has been reported, 4, 12, 26, 30 we sought to investigate whether TLR4 is an important mediator in retinal angiogenesis.
The presence of TLR4 on retinal pigment epithelium cells, photoreceptors, and glia and the resultant TLR signaling in retinal cells also suggest that these molecules may play an important role in innate and adaptive immune responses within the retina. [31] [32] [33] [34] Moreover, it has been reported that proinflammatory cytokines, such as transforming growth factor (TGF)-β1, interleukin (IL)-1β, and IL-6, were rapidly upregulated under ischemic conditions in astrocytes or Müllers cells, microglia, and endothelial cells in the retina in rat and mouse models. 35, 36 TLR4 signaling activation might be connected with the upregulation of those proinflammatory or angiogenic cytokines.
In this study, we established the retinal angiogenesis model through oxygen-induced retinopathy (OIR) in TLR4 −/− and wild-type (WT [C57BL/6J]) mice to determine the significance of HMGB1-TLR4 in the angiogenesis process of ischemia-induced retinal neovascularization (RNV). We found that TLR4 signaling was involved in the process of RNV. TLR4-deficiency retarded the HMGB1-TLR4 signaling responses and resulted in decreased RNV. HMGB1 from injured tissues triggered TLR4-dependent responses, also involving the activation of local astrocytes or Müllers cells, and the generation of a proinflammatory or proangiogenic factors. Our results revealed a role for HMGB1-TLR4 signaling in promoting neovascularization in neural tissue.
Methods
An expanded Methods section is available in the online-only Data Supplement.
Animals

TLR4
−/− mice were originally produced by Dr S. Akira (Osaka University, Osaka, Japan). Newborn animals of both TLR4 −/− and WT (C57BL/6J) (littermates of both sexes between 7 and 24 days old) from mature mice were used in all experiments. Animals were kept in a specific pathogen-free facility in Animal Laboratories of Zhongshan Ophthalmic Center, Guangzhou, China. All experiments were approved by the Institutional Animal Care and Use Committee.
Recombinant Full-Length HMGB1
The cloning, expression, and purification of recombinant full-length HMGB1 were carried out as previously described. 37 The recombinant proteins were highly purified and functional. In addition, to exclude lipopolysaccharide (LPS) contamination, we measured LPS content in purified HMGB1 by the chromogenic Limulus amebocyte lysate assay (QCL-1000; BioWhittaker, Walkersville, MD). The LPS content was <0.16 EU/mg (below the detection limit).
Established Retinal Angiogenesis Model in Mouse
According to a previously described method of Smith et al, 38 we used the following procedures to produce the OIR model. On postnatal day 7 (P7), the mouse pups (both TLR4 −/− and WT) and their nursing mother were placed in an airtight incubator (own production) ventilated by a mixture of oxygen and air to a final oxygen fraction of 75±5%. OIR mice were returned to normal room air at P12.
Quantification of RNV in the Flat-Mounted Retinas
Twenty TLR4
−/− and 20 WT-OIR mice were used for imaging quantification of RNV. On P12, P17, and P21, for fluorescein isothiocyanate (FITC)-dextran angiography, animals were anesthetized, and ≈1 mL high molecular weight FITC-dextran (diluted to concentration 50 mg/mL in PBS) was injected into the left ventricle and allowed to circulate. The neurosensory retinas were carefully removed and the radial cuts were made in the peripheral retina to allow whole flat-mounting on glass slides. For the Griffonia Simplicifolia (GS)-isolectin staining, the retinas were incubated for 2 hours at room temperature with biotinylated GS isolectin B4 diluted in PBS (1:100). Retinal whole mounts were examined by fluorescence microscopy (BH2-RFC, Olympus, Hamburg, Germany). According to a previously described method, [39] [40] [41] quantitative analysis of the vasculature and vascular obliteration were performed on the flat-mounted FITCdextran-perfused or GS isolactin staining retinas from each group by using a computerized system with Image-Pro Plus 5.1 software (Media Cybernetics).
Retinal Cross-Sections and Quantitation of Pre-ILM Neovascular Cell Nuclei
According to a previously described method, 38, 42, 43 on P12, P17, and P21, the animals (10 in each group) were euthanized and both eyes were enucleated and fixed, serially sectioned in their entirety for preinternal limiting membrane (ILM) nuclei counting. Over 50 serial 6-μm paraffin-embedded axial sections were obtained, and the standard hematoxylin and eosin staining was performed. All retinal vascular cell nuclei anterior to the ILM were counted in each section, using a fully masked protocol. The mean of the 10 counted sections yielded average neovascular cell nuclei per 6-μm section per eye.
Immunofluorescence Staining
The enucleated animal eyes were embedded in Tissue-Tek optimal cutting temperature compound (Sakura Fine Technical) overnight for cryosectioning, and then 5-µm serial sections were cut. The slides were incubated with primary antibodies TLR4, HMGB1, glial fibrillary acidic protein (GFAP), and CD31 in a humidified chamber overnight at 4°C in a double immunofluorescence staining manner (1:100 mouse anti-TLR4, 1:100 goat polyclonal anti-HMGB1; 1:500 rabbit anti-GFAP, and 1:100 rat anti-CD31 antibody). Then the slides were rinsed 3× with 0.01% phosphate-buffered saline and tween-20 and incubated with fluorescently labeled secondary antibodies.
Real-Time Quantitative RT-PCR for Detecting Gene Expression
Retinal specimens from 2 mice (4 eyes) were pooled together. Total RNAs were extracted from the mice retinal or cultured Müller cells, and the cDNA was prepared. Real-time polymerase chain reaction (PCR) was performed on an Applied Biosystems StepOne Real-Time PCR System using the comparative threshold cycle quantification method. Each reaction contained 12.5 μL of 2×SYBR green Master Mix, 300 nmol/L oligonucleotide primers for HMGB1, nuclear factor-kB, VEGF, b-FGF, TGF-β1, IL-1β, IL-6, TLR4, receptor for advanced glycation end products (RAGE) ( Table I in the online-only Data Supplement) synthesized by Invitrogen Biotechnology Co Ltd (Shanghai, China), 10 μL of 1 in 10 dilution of the cDNA and water, to a total of 25 μL.
Intraocular Injections With HMGB1
On P12, when TLR4 −/− or WT-OIR mice were returned to room air, they received intravitreal injections of HMGB1 in the right eye (twenty in each group). Intravitreal injections were performed using a 5-μL Hamilton syringe with a 32-gauge needle, according to a previously described method. 42, 44, 45 The eye was punctured at the upper nasal limbus, and a volume of 0.5 μL of HMGB1 solution (1.0 μg/ mL of recombinant HMGB1) or control vehicle, respectively, was injected in 1 eye of each mouse.
Retinal Glial Cell Culture and Treatment With HMGB1
Retinal glial cells were obtained from isolated retinas of postnatal day P7-12 WT and TLR4 −/− mice, using a method modified from Hicks and Courtois. 46 Briefly, retinas were dissected and cut into small pieces and incubated with culture medium. Müller cells were identified by immunofluorescence staining with GS (glutamine synthetase). After continuous incubation at 37°C in a humidified environment with 5% CO 2 for 2 days, Müller cells were washed with PBS, and cells were suspended in new medium. Müller cells were cultured at hypoxic condition (treated with CoCl 2 ). Then 1.0 μg/mL of recombinant HMGB1 or 0.1 μg/mL LPS (Sigma, St Louis, MO) and blank vehicle were added. For each treated well, cells were incubated for 24 hours, 36 hours, 48 hours, and 72 hours. After being washed with PBS, cells were split with 1 mL trizol (invitrogen) and exact RNA used for reverse transcriptase-PCR. In addition, Polymyxin B (10 μg/mL), a cyclic cationic polypeptide antibiotic known to specifically block the biological effect of LPS, was also included in Müller cells culture before HMGB1 treatment as a control group to exclude the LPS contamination.
Statistic Analysis
Representative results are shown in the figures. The means and SEM were calculated on all parameters determined in the study. Data were analyzed statistically using 1-way ANOVA or 2-tailed Student t test. A value of P<0.05 was accepted as statistically significant.
Results
TLR4 Is Involved in Ischemia-Induced Retinal Neovascularization in OIR Model
To evaluate the involvement of TLR4 in ischemia-induced retinal angiogenic response, we first examined neovascularization in TLR4-deficient mice in an OIR model. Figure 1 shows FITC-dextran-perfused retinas from 12, 17, and 21-day-old mice that had been exposed to hyperoxia from P7 to P12. In control WT mice, oxygen induction caused rapid RNV, which peaked at P17; however, in TLR4-deficient mice, a significant attenuated neovascularization was observed. In contrast, the normal vessels are more apparent in TLR4 −/− mice. Figure 2 shows typical immunostaining with GS isolectin, demonstrating the highest level of RNV at P17 (Figure 2A and 2B ).
The macroscopic RNV in WT mice reached a maximal level at P17 after oxygen induction, whereas a relatively small number of vessels appeared somewhat neovascular in TLR4-deficient OIR mice. Figure 2E and 2F are the representative photographs, illustrating neovascular cell nuclei anterior to the ILM. Consistent with the FITC-dextran-perfused retinas and GS-isolectin staining imaging analysis, the number of neovascular cell nuclei in the TLR4 −/− group is significantly decreased compared with the counterpart control ( Figure 2G ). In addition, we performed CD31 staining to further characterize neovascular cells as shown in the Figure I in the online-only Data Supplement. These observations indicate that TLR4 is involved in pathological retinal angiogenesis in the OIR model.
The Expression of TLR4 and HMGB1 in Ischemic Retina
Immunofluorescence analysis showed markedly enhanced TLR4 expression in ischemic retina compared with the lower level expression of TLR4 in normal retina in non-OIR mice ( Figure 3 ). Large numbers of TLR4-positive cells were displayed in the ischemic retina among the different layers, including ganglion cell layer, photoreceptors, and retinal pigment epithelium. To test whether HMGB1 is involved in ischemic retinopathy, we evaluated HMGB1 expression in the retina before and after ischemic injury in TLR4 −/− mice and WT mice. Figure 4 shows representative immunofluorescence staining of the retinal cryosections labeled with HMGB1, demonstrating the HMGB1 expression in both OIR models. HMGB1 mRNA expression analysis revealed that ischemic injury significantly enhanced the HMGB1 mRNA expression in WT-OIR mice. Interestingly, however, the magnitude of HMGB1 mRNA expression was markedly lower in TLR4 −/− mice concomitantly throughout a 5-day period of observation ( Figure 5 ). These results indicated that inactivation of TLR4 might result in impaired injury-induced HMGB1 production.
In addition, we have examined RAGE (another major receptor for HMGB1) expression in retina. Figure II in the online-only Data Supplement shows that there was a very low RAGE expression in normal and ischemic retina of OIR model. However, there was a remarkably increased expression of TLR4 mRNA in OIR retina. 
TLR4 Is Associated With the Glia Activation in OIR
Given that TLR4 is expressed on glia to mediate inflammatory responses 31 and that activation of glial cells, such as astrocytes and Müller cells, are related to the new blood vessel growth, 47 we examined the effects of TLR4 on Müller cell activation in ischemic retina in TLR4-deficiency mice. Double Similarly, Figure 4 revealed that HMGB1 was significantly increased and distributed in ILM, ganglion cell layer, and inner nuclear layer of the retina with more intensive GFAP positive astrocytes and Müller cells in WT OIR model, whereas less HMGB1 was released in TLR4 −/− OIR retina with a less GFAP immunoreactivity of astroctyes or Müller cells. These observations indicate that TLR4 is critical for activation of astrocytes and Müller cells in ischemic retina.
TLR4 Is Required for the Ischemic-Induced Proinflammatory Factor Gene Expression In Vivo
Retinal glial cells are a rich source of growth factors. Müller cell activation often resulted in release of proinflammatory or proangiogenic factors. Markedly attenuated Müller cell activation implied that proinflammatory or proangiogenic factor expressions might be downregulated in ischemic TLR4 −/− retina. To test this hypothesis, quantitative real-time PCR (n=10) was used to examine the changes in mRNA expression of these proinflammatory or proangiogenic factors, including nuclear factor-kB, VEGF, b-FGF, TGF-β1, IL-1β, and IL-6 in ischemic retina. Ischemic injury markedly increased retinal mRNA expression of these proinflammatory or proangiogenic factors in WT and TLR4 −/− mice throughout the 5-day period of observation, but to different extents ( Figure 6 ). The level of enhancement was significantly lower in TLR4 −/− OIR retina with the expression of VEGF decreased 2.37-fold, b-FGF decreased 0.61-fold, IL-1β decreased 0.67-fold, and IL-6 decreased 0.96-fold on day 17 as compared with WT-OIR retina. These results suggest that the TLR4 signaling pathway plays a critical role in proangiogenic factor production by activating glia in the ischemia retina. The reliability of the quantitative reverse transcriptase-PCR data were further verified, as similar results were also obtained by normalizing quantitative reverse transcriptase-PCR results with expression of the β-actin, another selected housekeeping gene (Data shown in Figure IV in the online-only Data Supplement).
HMGB1 Activated TLR4 and Promoted the Angiogenic Factor Expression
In vivo, we performed intraocular injection with HMGB1 in an OIR model. We found significantly increased mRNA expression for VEGF, b-FGF, and IL-6 in the WT-OIR 
Discussion
Ischemia-induced RNV has been reported to be associated with inflammation. [48] [49] [50] This study demonstrated that activation of TLR4 signaling-associated inflammatory response contributes to neovascularization in the retina of the ischemiainduced angiogenesis model.
Without exogenous pathogen-associated ligands, TLR4 could be activated by HMGB1, an endogenous agonist produced by damaged tissue or infiltrating immune cells in the injured sites. 6 In this study, the findings revealed that oxygeninduced retinal injury promotes the expression of HMGB1 and TLR4, indicating that ischemia initiates HMGB1-TLR4 signaling pathway in the retina. Furthermore, HMGB1 release is associated with TLR4 expression, and TLR4 ablation suppresses the release of HMGB1, indicating that their interaction may regulate RNV through an autocrine or paracrine mechanism. Exogenous HMGB1 intraocular injection enhanced the production of proinflammatory factors in the WT-OIR model, but not in TLR4 −/− OIR mice, further suggesting that HMGB1-TLR4 signaling plays an important role in immune-inflammation-mediated retinal angiogenesis. To date, 3 putative HMGB1 receptors have been reported: RAGE, TLR4, and TLR2. 51, 52 Our data showed that there was a very low RAGE expression in normal and ischemic retina of OIR model, however, a remarkably increased expression of TLR4 mRNA in OIR retina ( Figure II in the online-only Data Supplement). Furthermore, we found HMGB1-induced angiogenesis was suppressed in TLR4 −/− mice, but not in TLR2 −/− mice (data not shown). These data suggest that TLR4 may play a predominant role as a major receptor of HMGB1 in RNV.
HMGB1-TLR4 axis has been implicated in the inflammatory process of several vasculature-related disease models. 7, [53] [54] [55] In a previous study, 17 we demonstrated that HMGB1-TLR4 signaling is involved in angiogenesis in a mouse model of alkali-induced corneal neovascularization, which is a typical injury-induced inflammatory reaction model. Whereas the retina is a neural tissue, it is highly sensitive in response to oxygen deficiency. Different from alkali-induced corneal neovascularization model, the OIR model used in this study is a typical angiogenesis model attributable to ischemia. 38, 42, 43 This model can reflect the angiogenesis in ischemic neural tissue appropriately and can be used extensively in the general study of many different diseases with ischemic pathological neovascularization.
HMGB1-TLR4 signaling has also been demonstrated to play an important role in cell apoptosis and necrosis in the central nervous system. 21, 28 However, those studies focused on the inflammatory responses associated with the damage of neural tissue, and did not concern vascular disorder in central nervous system. To our knowledge, the angiogenesis mediated by HMGB1-TLR4 in ischemic neural tissue has not been reported. In this study, we found that ischemia could initiate the HMGB1-TLR4 signaling pathway in retina, which is a special nervous tissue arranged by accurate neuron and glia network and microvascular network. The findings showed that only a very small number of vessels appeared somewhat neovascular in neural retina of TLR4-deficient mice under hypoxia, whereas the RNV reached a maximal level at P17 in the WT-OIR model. Therefore, the HMGB1-TLR4 inflammatory signaling pathway also contributes to the angiogenesis in the retinal neural tissue.
The downstream pathway of the TLR4 signaling regarding VEGF production and its effect on angiogenesis has been demonstrated in angiogenic response in damaged tissue. 56, 57 Recently, Biscetti 58 has reported that HMGB1 promotes angiogenesis through VEGF-dependent mechanism in peripheral ischemia model in diabetic mice. A significant reduction in HMGB1-induced angiogenesis was observed when VEGF activity was suppressed. Consistent with those findings, we found that the absence of TLR4 can attenuate the activity of nuclear factor-κB and the production of VEGF. Along with the attenuated HMGB1 expression and RNV profile in retinal flat mount slides, there was significantly decreased VEGF mRNA expression in TLR4 −/− OIR mice as compared with the WT-OIR mice. Meanwhile, there is also a marked downregulation of proinflammatory factors, such as b-FGF, TGF-β1, IL-6, and IL-1β, also as proangiogenic factors. Therefore, the inactivation of TLR4 diminished the cytokine cascade and attenuated the retinal pathological neovascularization, which might imply that there is corresponding attenuated activity of inflammation-associated cells.
Interestingly, in this study, we also found that there was an obviously attenuated expression of GFAP in retinal glia (astrocytes and Müllers cells) in the TLR4 −/− OIR model compared with the WT-OIR model. As we know, retinal glia have been demonstrated to be significantly activated in ischemic retina in the OIR model. 59, 60 The activated astrocytes can induce the expression of VEGF and some other cytokines, promoting revascularization to resupply oxygen. 61, 62 In vitro, we found that there is significant expression of TLR4 in Müller cells under hypoxia, and LPS or HMGB1 treatment could lead to significantly increased production of proinflammatory cytokines. These findings indicated that TLR4 signaling is also related to glia (astrocytes or Müller cells) activation. Actually, glia in the retina could be served as immune cells in some conditions. 63, 64 Although these findings could not exclude the role of the infiltrating macrophages with TLR4 expression, the resident-activated glia must be at least somewhat involved in TLR4 signaling-associated retinal angiogenesis. In our study, TLR4 −/− OIR mice experienced attenuated Müller cells activation, represented by decreased GFAP expression, indicating that there will be a new paradigm in exploring the role and mechanism of immune-inflammatory response mediated by glia in angiogenesis, particularly in ischemic neural tissue.
In summary, using an acute oxygen-induced ischemic retinopathy model in TLR4 −/− and WT mice, we discovered an unrecognized pathway involving HMGB1 and its interaction with TLR4 in retinal angiogenesis. Our results suggest that TLR4-deficiency could retard the HMGB1-TLR4-mediated response and downregulate the expression of nuclear factor-κB and VEGF, resulting in decreased neovascularization. In addition, retinal glia activation is involved in the TLR4-associated inflammatory-angiogenesis in the retina. These results represent a previously unrecognized effect of TLRs on RNV and reveal a new potential mechanism of angiogenesis associated with glia activation in ischemic neural tissue. It means that the extent of RNV with ischemia depends on the immunoinflammation-associated TLR4 gene background to some extent. Thus, targeting the HMGB1-TLR4 signaling cascade may constitute a novel therapeutic approach to angiogenesis-related diseases.
Disclosures
None. 
